|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
18
|
|
pubmed:dateCreated |
2005-6-17
|
|
pubmed:abstractText |
We reviewed follow-up of patients treated in 19 randomized trials of adjuvant epirubicin in early breast cancer to determine incidence, risk, and risk factors for subsequent acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BerghJonasJ,
pubmed-author:BlissJudithJ,
pubmed-author:BonneterreJacquesJ,
pubmed-author:CesanaBrunoB,
pubmed-author:CoombesR CharlesRC,
pubmed-author:FargeotPierreP,
pubmed-author:FolinAnnikaA,
pubmed-author:FumoleauPierreP,
pubmed-author:GiulianiRosaR,
pubmed-author:HeryMichelM,
pubmed-author:KerbratPierreP,
pubmed-author:NilssonJonasJ,
pubmed-author:OnidaFrancescoF,
pubmed-author:PiccartMartineM,
pubmed-author:PragaClaudioC,
pubmed-author:RogersDavidD,
pubmed-author:ShepherdLoisL,
pubmed-author:TherassePatrickP,
pubmed-author:WilsJacquesJ
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
20
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4179-91
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15961765-Adult,
pubmed-meshheading:15961765-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15961765-Breast Neoplasms,
pubmed-meshheading:15961765-Chemotherapy, Adjuvant,
pubmed-meshheading:15961765-Cyclophosphamide,
pubmed-meshheading:15961765-Data Interpretation, Statistical,
pubmed-meshheading:15961765-Epirubicin,
pubmed-meshheading:15961765-Female,
pubmed-meshheading:15961765-Follow-Up Studies,
pubmed-meshheading:15961765-Humans,
pubmed-meshheading:15961765-Leukemia, Myeloid, Acute,
pubmed-meshheading:15961765-Middle Aged,
pubmed-meshheading:15961765-Myelodysplastic Syndromes,
pubmed-meshheading:15961765-Randomized Controlled Trials as Topic,
pubmed-meshheading:15961765-Risk Factors
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide.
|
|
pubmed:affiliation |
Centre Oscar Lambret, Lille, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
